Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1977 Apr;32(4):475–481.

Identity of a T-lymphocyte inhibitor with mouse immunoglobulin in the serum of tumour-bearing mice.

J G Levy, R McMaster, B Kelly, R B Whitney, D G Kilburn
PMCID: PMC1445475  PMID: 305409

Abstract

A component of the serum of tumour-bearing mice has been shown to be inhibitory to the immunological function of normal mouse T cells. This factor fractionates with monomeric immunoglobulin upon gel filtration. Studies were carried out utilizing goat antisera to the major immunoglobulin chains of mouse Ig (kappa, gamma, alpha and mu) mixed with the immunoglobulin-rich fraction of serum from normal mice and tumour bearers and passed through immunoadsorbent columns prepared with rabbit anti-goat immunoglobulin. Such studies showed that the inhibitory activity in tumour-bearing serum could be removed after treatment with anti-kappa, anti-gamma and anti-mu chain antisera but not by treatment with either anti-alpha chain or goat immunoglobulin. That the inhibitory activity of tumour-bearing immunoglobulin could be attributed to simple quantitative differences in the levels of IgM and IgG in the test samples was discounted by quantification of the amounts of immunoglobulins in normal and tumour-bearing sera.

Full text

PDF
475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berkowitz D. M., Alexander L., Hollenberg N. K. A simple cell-suspension method for transplantation of V2 carcinoma. J Natl Cancer Inst. 1975 Jan;54(1):233–234. doi: 10.1093/jnci/54.1.233. [DOI] [PubMed] [Google Scholar]
  2. Brooks W. H., Netsky M. G., Normansell D. E., Horwitz D. A. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med. 1972 Dec 1;136(6):1631–1647. doi: 10.1084/jem.136.6.1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fernbach B. R., Kirchner H., Bonnard G. D., Herberman R. B. Suppression of mixed lymphocyte response in mice bearing primary tumors induced by murine sarcoma virus. Transplantation. 1976 May;21(5):381–386. doi: 10.1097/00007890-197605000-00004. [DOI] [PubMed] [Google Scholar]
  4. Gotschlich E. C., Edelman G. M. Binding properties and specificity of C-reactive protein. Proc Natl Acad Sci U S A. 1967 Mar;57(3):706–712. doi: 10.1073/pnas.57.3.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gotschlich E. C., Edelman G. M. C-reactive protein: a molecule composed of subunits. Proc Natl Acad Sci U S A. 1965 Aug;54(2):558–566. doi: 10.1073/pnas.54.2.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HEIMER R., SCHWARTZ E. R., ENGLE R. L., Jr, WOODS K. R. THE RELATIONSHIP OF STRUCTURE TO THE THERMAL SOLUBILITY CHARACTERISTICS OF A BENCE-JONES PROTEIN. Biochemistry. 1963 Nov-Dec;2:1380–1386. doi: 10.1021/bi00906a034. [DOI] [PubMed] [Google Scholar]
  7. Levy J. G., Smith A. G., Whitney R. B., McMaster R., Kilburn D. G. Characterization of a T-lymphocyte inhibitor in the serum of tumour-bearing mice. Immunology. 1976 Apr;30(4):565–573. [PMC free article] [PubMed] [Google Scholar]
  8. Mortensen R. F., Gewurz H. Effects of C-reactive protein on the lymphoid system. II. Inhibition of mixed lymphocyte reactivity and generation of cytotoxic lymphocytes. J Immunol. 1976 May;116(5):1244–1250. [PubMed] [Google Scholar]
  9. Nimberg R. B., Glasgow A. H., Menzoian J. O., Constantian M. B., Cooperband S. R., Mannick J. A., Schmid K. Isolation of an immunosuppressive peptide fraction from the serum of cancer patients. Cancer Res. 1975 Jun;35(6):1489–1494. [PubMed] [Google Scholar]
  10. Porath J., Axen R., Ernback S. Chemical coupling of proteins to agarose. Nature. 1967 Sep 30;215(5109):1491–1492. doi: 10.1038/2151491a0. [DOI] [PubMed] [Google Scholar]
  11. Suciu-Foca N., Buda J., McManus J., Thiem T., Reemtsma K. Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer. Cancer Res. 1973 Oct;33(10):2373–2377. [PubMed] [Google Scholar]
  12. Vandenbark A. A., Burger D. R., Finke P., Vetto R. M. The effects of plasma from guinea pigs with tumor on PHA stimulated lymphocyte cultures. Cell Immunol. 1976 Mar 15;22(2):334–344. doi: 10.1016/0008-8749(76)90034-4. [DOI] [PubMed] [Google Scholar]
  13. Whitney R. B., Levy J. G. Mode of action of immunosuppressive substances in sera of tumor-bearing mice. J Natl Cancer Inst. 1975 Dec;55(6):1447–1452. doi: 10.1093/jnci/55.6.1447. [DOI] [PubMed] [Google Scholar]
  14. Whitney R. B., Levy J. G., Smith A. G. Influence of tumor size and surgical resection on cell-mediated immunity in mice. J Natl Cancer Inst. 1974 Jul;53(1):111–116. doi: 10.1093/jnci/53.1.111. [DOI] [PubMed] [Google Scholar]
  15. Whitney R. B., Levy J. G. Suppression of mitogen responses by serum from tumour-bearing mice. Eur J Cancer. 1974 Nov;10(11):739–745. doi: 10.1016/0014-2964(74)90113-3. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES